Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside …

MP Mingeot-Leclercq, JL Décout - MedChemComm, 2016 - pubs.rsc.org
Hereunder, we highlight bacterial membrane anionic lipids as attractive targets in the design
of antibacterial drugs which can be effective against both Gram-positive and Gram-negative …

The future of aminoglycosides: the end or renaissance?

JL Houghton, KD Green, W Chen… - …, 2010 - Wiley Online Library
Although aminoglycosides have been used as antibacterials for decades, their use has
been hindered by their inherent toxicity and the resistance that has emerged to these …

Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections

KJ Labby, S Garneau-Tsodikova - Future medicinal chemistry, 2013 - Taylor & Francis
Shortly after the discovery of the first antibiotics, bacterial resistance began to emerge. Many
mechanisms give rise to resistance; the most prevalent mechanism of resistance to the …

Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities

NT Chandrika, S Garneau-Tsodikova - Chemical Society Reviews, 2018 - pubs.rsc.org
A systematic analysis of all synthetic and chemoenzymatic methodologies for the
preparation of aminoglycosides for a variety of applications (therapeutic and agricultural) …

Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases

M Hainrichson, I Nudelman, T Baasov - Organic & biomolecular …, 2008 - pubs.rsc.org
Aminoglycosides are highly potent, broad-spectrum antibiotics that exert their bactericidal
therapeutic effect by selectively binding to the decoding aminoacyl site (A-site) of the …

New trends in the use of aminoglycosides

MY Fosso, Y Li, S Garneau-Tsodikova - MedChemComm, 2014 - pubs.rsc.org
Despite their inherent toxicity and the acquired bacterial resistance that continuously
threaten their long-term clinical use, aminoglycosides (AGs) still remain valuable …

Synthesis and bioactivities of kanamycin B-derived cationic amphiphiles

MY Fosso, SK Shrestha, KD Green… - Journal of medicinal …, 2015 - ACS Publications
Cationic amphiphiles derived from aminoglycosides (AGs) have been shown to exhibit
enhanced antimicrobial activity. Through the attachment of hydrophobic residues such as …

Targeted modifications of neomycin and paromomycin: Towards resistance-free antibiotics?

J Obszynski, H Loidon, A Blanc, JM Weibel, P Pale - Bioorganic chemistry, 2022 - Elsevier
Despite their clinical importance, saving numerous human lifes, over-and mis-uses of
antibiotics have created a strong selective pressure on bacteria, which induces the …

A review of patents (2011–2015) towards combating resistance to and toxicity of aminoglycosides

NT Chandrika, S Garneau-Tsodikova - MedChemComm, 2016 - pubs.rsc.org
Since the discovery of the first aminoglycoside (AG), streptomycin, in 1943, these broad-
spectrum antibiotics have been extensively used for the treatment of Gram-negative and …

New broad-spectrum antibacterial amphiphilic aminoglycosides active against resistant bacteria: from neamine derivatives to smaller neosamine analogues

L Zimmermann, I Das, J Désiré, G Sautrey… - Journal of Medicinal …, 2016 - ACS Publications
Aminoglycosides (AGs) constitute a major family of potent and broad-spectrum antibiotics
disturbing protein synthesis through binding to the A site of 16S rRNA. Decades of …